Form4insider filings, from the source

SEC Form 4 · accession 0001104659-17-018108

BeOne Medicines Ltd. · ONC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
John Oyler
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
Mar 16, 2017
Accepted (ET)
Mar 20, 2017 · 7:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001651308

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
American Depositary SharesF1,F3Mar 16, 2017S15,838$38.7581D197,640D
American Depositary SharesF1Mar 16, 2017S200$39.37D197,440D
American Depositary SharesF1,F4Mar 17, 2017S2,717$40.0209D194,723D
American Depositary SharesF1,F5Mar 20, 2017S13,234$40.019D181,489D
Ordinary Sharesholding———23,436,468D
Ordinary SharesF6holding———29,890,174ISee footnote
Ordinary SharesF7holding———10,000,000ISee footnote
Ordinary SharesF8holding———102,188ISee footnote
Ordinary SharesF9holding———8,000,000ISee footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses